United States

Back to map

Showing 241-250 of 353 grants

Title Institution Researcher Program Duration Total Award Amount
Optimizing islet cell graft performance with targeted alpha and beta cell composition and distribution Mayo Clinic Quinn Peterson Cures 01-April-2025 to 31-March-2027 $699.138,64
A Nanosensor Embedded Device for Rapid Insulin Measurement Massachusetts Institute of Technology Michael Strano Improving Lives 01-April-2024 to 31-March-2027 $698.927,98
The T1D Parent Check-In: A Preventative Intervention Massachusetts General Hospital Ellen O’Donnell Improving Lives 01-July-2023 to 01-September-2026 $390.792,17
Understanding common tissue tolerance mechanisms in autoimmunity Massachusetts General Hospital Gary Reynolds Cures 01-September-2025 to 28-February-2027 $150.000,00
Epithelial Immune Sentinels in T1D Autoimmune Kidney Disease Massachusetts General Hospital Maria Agustina Battistone Improving Lives 01-September-2026 to 31-August-2028 $189.099,97
Development and testing of protease-resistant CXCL12 loaded sub 100 micron polymeric microbeads to enable alloislet transplantation without systemic immune suppression in established murine models of type 1 diabetes Massachusetts General Hospital Mark Poznansky Cures 01-February-2026 to 31-January-2028 $599.448,76
Development of a safe and effective islet-targeted nanoplasmid based CXCL12 gene delivery system using cationic nanobubble-mediated sonotransfection to restore and immune protect the residual beta cell mass in T1D Massachusetts General Hospital Mark Poznansky Cures 01-April-2023 to 31-March-2027 $777.168,00
INHALE-1st: Technosphere Insulin (Afrezza®) In Combination With Basal Insulin For Youth With Newly-Diagnosed Type 1 Diabetes Mannkind Ian Buckner Improving Lives 25-June-2026 to 24-June-2028 $600.000,00
Transcriptional memory in human islet organogenesis Lundquist Institute for Biomedical Medical Innovation at Harbor‐UCLA Medical Center (The Lundquist Institute) Eiji Yoshihara Cures 01-April-2022 to 31-March-2027 $749.995,50
Assessment of NovoSphere™ Hydrogel Encapsulation to Enable High-Loading and Extended Release of Tegoprubart for Subcutaneous Administration Likarda, Inc Lisa Stehno-Bittel Cures 15-June-2026 to 15-December-2026 $301.200,00